15-12G 1 ny20008100x3_15-12g.htm 15-12G

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 15

CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION

UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934

OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d)

OF THE SECURITIES EXCHANGE ACT OF 1934.

Commission File Number 001-37929

MYOVANT SCIENCES LTD.

(Exact name of registrant as specified in its charter)

7th Floor

50 Broadway

London

SW1H 0DB

United Kingdom

+44 207 400 3351

(Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices)

Common Shares, par value $0.000017727 per share

(Title of each class of securities covered by this Form)

None

(Titles of all other classes of securities for which a duty to file reports under section 13(a) or 15(d) remains)

Please place an X in the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:

	Rule 12g-4(a)(1)	☒
	Rule 12g-4(a)(2)	☐
	Rule 12h-3(b)(1)(i)	☒
	Rule 12h-3(b)(1)(ii)	☐
	Rule 15d-6	☐
	Rule 15d-22(b)	☐

Approximate number of holders of record as of the certification or notice date: 1

Pursuant to the requirements of the Securities Exchange Act of 1934, Myovant Sciences Ltd. has caused this certification/notice to be signed on its behalf by the undersigned duly authorized person.

Date: March 20, 2023	MYOVANT SCIENCES LTD.


	By:	/s/ Matthew Lang
	Name:	Matthew Lang
	Title:	General Counsel

SEC Form 15-12G filed by Myovant Sciences Ltd.